Thermo Fisher Scientific Inc. (TMO) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Thermo Fisher Scientific Inc. (TMO) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

TMO Income Statement

Thermo Fisher Scientific Inc. (TMO) annual income statement — 30-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	12.14B	11.99B	11.01B	12.21B	11.12B	10.85B	10.36B	11.39B	10.6B	10.54B	10.35B	10.89B	10.57B	10.69B	10.71B	11.45B	10.68B	10.97B	11.82B	10.7B
Revenue Growth %	9.13%	10.5%	6.18%	7.2%	4.94%	2.97%	0.18%	4.68%	0.23%	-1.37%	-3.41%	-4.93%	-0.96%	-2.58%	-9.38%	6.99%	14.44%	18.3%	19.3%	1.44%
Cost of Goods Sold	6.95B	7.05B	6.53B	7.2B	6.54B	6.45B	6.12B	6.93B	6.25B	6.2B	6.13B	6.93B	6.24B	6.42B	6.53B	7.29B	6.36B	6.38B	6.33B	5.77B
COGS % of Revenue	57.22%	58.79%	59.33%	58.98%	58.79%	59.39%	59.04%	60.8%	59.02%	58.79%	59.24%	63.69%	59.03%	60.05%	60.93%	63.69%	59.53%	58.2%	53.6%	53.93%
Gross Profit	5.19B	4.94B	4.48B	5.01B	4.58B	4.41B	4.25B	4.47B	4.34B	4.34B	4.22B	3.95B	4.33B	4.27B	4.18B	4.16B	4.32B	4.59B	5.48B	4.93B
Gross Margin %	42.78%	41.21%	40.67%	41.02%	41.21%	40.61%	40.96%	39.2%	40.98%	41.21%	40.76%	36.31%	40.97%	39.95%	39.07%	36.31%	40.47%	41.8%	46.4%	46.07%
Gross Profit Growth %	13.29%	12.14%	5.44%	12.18%	5.53%	1.47%	0.66%	13%	0.25%	1.76%	0.79%	-4.91%	0.25%	-6.91%	-23.71%	-15.68%	-6.96%	1.12%	5.36%	-6.77%
Operating Expenses	2.93B	2.86B	2.61B	2.71B	2.51B	2.49B	2.42B	2.2B	2.43B	2.59B	2.5B	1.96B	2.36B	2.49B	2.48B	2.17B	2.56B	2.65B	2.64B	2.25B
OpEx % of Revenue	24.13%	23.81%	23.74%	22.17%	22.55%	22.96%	23.35%	19.3%	22.9%	24.53%	24.14%	18.02%	22.3%	23.28%	23.16%	18.97%	24.01%	24.11%	22.36%	21.03%
Selling, General & Admin	1.86B	1.91B	1.8B	2.35B	2.16B	2.14B	2.08B	1.82B	2.08B	2.25B	2.17B	1.64B	2.04B	2.14B	2.13B	1.78B	2.21B	2.28B	2.28B	1.86B
SG&A % of Revenue	15.35%	15.92%	16.34%	19.25%	19.44%	19.72%	20.05%	16.02%	19.64%	21.32%	20.94%	15.02%	19.28%	20.05%	19.93%	15.55%	20.73%	20.78%	19.28%	17.37%
Research & Development	348M	364M	336M	357M	347M	352M	342M	374M	346M	339M	331M	327M	319M	345M	346M	391M	351M	365M	364M	392M
R&D % of Revenue	2.87%	3.03%	3.05%	2.92%	3.12%	3.24%	3.3%	3.28%	3.26%	3.22%	3.2%	3%	3.02%	3.23%	3.23%	3.41%	3.29%	3.33%	3.08%	3.66%
Other Operating Expenses	1000K	1000K	1000K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	2.26B	2.09B	1.86B	2.3B	2.08B	1.92B	1.84B	2.27B	1.92B	1.76B	1.72B	1.99B	1.97B	1.78B	1.7B	1.99B	1.76B	1.94B	2.84B	2.68B
Operating Margin %	18.65%	17.4%	16.93%	18.85%	18.66%	17.66%	17.75%	19.9%	18.08%	16.68%	16.63%	18.29%	18.67%	16.67%	15.91%	17.34%	16.46%	17.69%	24.05%	25.03%
Operating Income Growth %	9.06%	8.87%	1.25%	1.5%	8.3%	9.04%	6.98%	13.91%	-2.94%	-1.29%	0.94%	0.3%	12.35%	-8.24%	-40.04%	-25.91%	-25.17%	-13.77%	-7.58%	-14.57%
EBITDA	2.5B	2.9B	2.6B	3.03B	2.74B	2.6B	2.54B	3.01B	2.66B	2.55B	2.56B	2.83B	2.83B	2.64B	2.56B	2.83B	2.6B	2.78B	3.7B	3.36B
EBITDA Margin %	20.64%	24.21%	23.62%	24.81%	24.6%	23.97%	24.56%	26.42%	25.06%	24.17%	24.71%	26%	26.74%	24.67%	23.93%	24.74%	24.3%	25.31%	31.32%	31.41%
EBITDA Growth %	-8.44%	11.61%	2.12%	0.66%	3.01%	2.12%	-0.43%	6.36%	-6.05%	-3.34%	-0.27%	-0.11%	8.94%	-5.08%	-30.75%	-15.73%	-12.8%	-4.6%	0.14%	-10.06%
D&A (Non-Cash Add-back)	0	817M	736M	728M	661M	685M	705M	742M	740M	790M	836M	839M	853M	855M	859M	848M	838M	836M	859M	683M
EBIT	2.5B	2.09B	1.88B	2.49B	2.17B	2.11B	1.92B	2.33B	2.17B	2.19B	1.95B	2.18B	2.16B	1.76B	1.66B	2.05B	1.77B	2.06B	2.68B	2.02B
Net Interest Income	-165M	-194M	-121M	-107M	-113M	-107M	-100M	-157M	-147M	-126M	-84M	-135M	-147M	-148M	-154M	-119M	-105M	-112M	-118M	-150M
Interest Income	252M	207M	233M	258M	234M	297M	203M	227M	277M	295M	279M	309M	246M	178M	146M	150M	68M	36M	18M	11M
Interest Expense	417M	401M	354M	365M	347M	404M	303M	384M	424M	421M	363M	444M	393M	326M	300M	269M	173M	148M	136M	161M
Other Income/Expense	-175M	-163M	-129M	-179M	-247M	-206M	-234M	-294M	-188M	-77M	-108M	-252M	-226M	-367M	-366M	-238M	-228M	-75M	-321M	-818M
Pretax Income	2.09B	1.92B	1.73B	2.12B	1.83B	1.71B	1.61B	1.97B	1.73B	1.68B	1.61B	1.74B	1.75B	1.41B	1.34B	1.75B	1.53B	1.87B	2.52B	1.86B
Pretax Margin %	17.2%	16.04%	15.76%	17.38%	16.44%	15.76%	15.5%	17.32%	16.3%	15.95%	15.58%	15.97%	16.53%	13.23%	12.49%	15.26%	14.32%	17.01%	21.33%	17.39%
Income Tax	352M	167M	70M	153M	207M	92M	95M	150M	99M	128M	281M	133M	53M	52M	46M	173M	31M	198M	301M	202M
Effective Tax Rate %	16.86%	8.68%	4.04%	7.21%	11.32%	5.38%	5.92%	7.6%	5.73%	7.61%	17.43%	7.65%	3.03%	3.68%	3.44%	9.9%	2.03%	10.61%	11.94%	10.85%
Net Income	1.72B	1.74B	1.65B	1.98B	1.62B	1.62B	1.51B	1.83B	1.63B	1.55B	1.33B	1.63B	1.72B	1.36B	1.29B	1.58B	1.5B	1.66B	2.21B	1.66B
Net Margin %	14.18%	14.47%	15%	16.17%	14.53%	14.9%	14.54%	16.06%	15.38%	14.69%	12.84%	14.97%	16.22%	12.74%	12.04%	13.76%	14%	15.17%	18.74%	15.49%
Net Income Growth %	6.5%	7.36%	9.56%	7.92%	-0.86%	4.46%	13.48%	12.27%	-4.96%	13.74%	3.03%	3.43%	14.72%	-18.21%	-41.81%	-4.95%	-21.4%	-8.97%	-5.22%	-33.63%
Net Income (Continuing)	1.74B	1.76B	1.66B	1.97B	1.62B	1.62B	1.51B	1.82B	1.63B	1.55B	1.33B	1.61B	1.7B	1.36B	1.29B	1.57B	1.5B	1.67B	2.22B	1.66B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	6M	7M	128M	129M	136M	91M	95M	87M	107M	103M	107M	107M	136M	163M	176M	170M	178M	178M	175M	184M
EPS (Diluted)	4.64	4.68	4.43	5.21	4.27	4.28	3.98	4.78	4.24	4.04	3.46	4.20	4.42	3.51	3.32	4.01	3.78	4.22	5.61	4.17
EPS Growth %	8.67%	9.35%	11.31%	9%	0.71%	5.94%	15.03%	13.81%	-4.07%	15.1%	4.22%	4.74%	16.93%	-16.82%	-40.82%	-3.84%	-21.09%	-8.46%	-4.59%	-33.17%
EPS (Basic)	4.65	4.68	4.44	5.22	4.28	4.28	3.99	4.79	4.27	4.05	3.48	4.21	4.44	3.53	3.34	4.03	3.81	4.24	5.65	4.20
Diluted Shares Outstanding	371M	371M	373M	377M	378M	378M	379M	383M	384M	383M	384M	388M	388M	388M	388M	393M	395M	394M	395M	398M
Basic Shares Outstanding	370M	371M	372M	376M	378M	378M	378M	382.85M	382M	382M	382M	387M	386M	386M	386M	391M	392M	392M	392M	394M
Dividend Payout Ratio	10.11%	10.08%	9.81%	8.2%	10.09%	10.02%	9.89%	8.14%	9.2%	9.63%	10.17%	8.34%	7.87%	9.92%	9.08%	7.42%	7.89%	7.03%	4.65%	6.21%